Disrupting IFIT1-STAT2 viral evasion synergy yields live-attenuated flavivirus with enhanced immune priming
Amporn Suphatrakul, Warangkana Chantima, Pratsaneeyaporn Posiri, Nittaya Srisuk et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Warangkana Chantima
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
35Publications signalées
500Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studiesvaccines and immunoinformatics approachesImmunotherapy and Immune Responses
Publications récentes
Central Nervous System Involvement by Novel Clade 2.3.2.1e H5N1 Avian Influenza Virus in a Pediatric Patient
Phung Nguyen The Nguyen, Nguyễn Thanh Hùng, Ngo Ngọc Quang Minh, Nguyen Thi Thu Hong et autres
0 citationsOpen Forum Infectious Diseases
Longitudinal analysis of neutralizing antibodies against SARS-CoV-1 and different SARS-CoV-2 strains in breakthrough and unvaccinated COVID-19 patients in Thailand (2021-2022)
Prapassorn Poolchanuan, Vichapon Tiacharoen, Adul Dulsuk, Rungnapa Phunpang et autres
0 citationsScientific Reports
Age associated SARS-CoV-2 immune responses provide insights into population immunity over four years since the COVID-19 pandemic
Nungruthai Suntronwong, Suvichada Assawakosri, Sirapa Klinfueng, Thaneeya Duangchinda et autres
4 citationsScientific Reports
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
Nungruthai Suntronwong, Sitthichai Kanokudom, Thaneeya Duangchinda, Warangkana Chantima et autres
10 citationsScientific Reports
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
Suwarti Suwarti, Sabighoh Zanjabila, Robert Sinto, Fransiska Fransiska et autres
7 citationsBMC Infectious Diseases
Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Lakkhana Wongsrisang et autres
3 citationsVaccine X
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, Thanunrat Thongmee et autres
6 citationsVaccines
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination
Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, Jira Chansaenroj et autres
6 citationsHeliyon
Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity
Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Preeyaporn Vichaiwattana et autres
8 citationsInternational Journal of Infectious Diseases
Comparison of the reactogenicity and immunogenicity between two‐dose mRNA COVID‐19 vaccine and inactivated COVID‐19 vaccine followed by an mRNA vaccine in children aged 5−11 years
Nasamon Wanlapakorn, Sitthichai Kanokudom, Harit Phowatthanasathian, Jira Chansaenroj et autres
4 citationsJournal of Medical Virology
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3 to 4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination
Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, Jira Chansaenroj et autres
2 citationsmedRxiv
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.